Oct 2024 1 Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for Commercializing the specialty product FIBROMUN
Sep 2024 27 Philogen to attend the European Association of Nuclear Medicine (EANM) annual meeting on October 19-23, 2024
